Research and Development is at the core of transforming scientific ideas into life-saving medicines. At Quraxia, we collaborate closely with pharmaceutical and biotech partners to design and execute R&D strategies that accelerate discovery, optimize development, and enhance product success. Whether advancing early-stage research or preparing molecules for clinical development, we are your trusted innovation partner throughout the journey.
As a science-driven organization, Quraxia combines extensive expertise with state-of-the-art technologies and a collaborative mindset. Our streamlined R&D processes are designed to deliver precise, reliable data and solutions aligned with evolving industry standards and regulatory expectations. This approach helps reduce development risks, shorten timelines, and improve the chances of clinical and commercial success.
From target discovery and biomarker identification to advanced synthesis and disease modeling, our R&D practice is comprehensive, agile, and focused on quality. We integrate scientific rigor with practical experience to help you navigate complex challenges and translate promising molecules into effective therapies.
High-quality, well-executed research and development forms the bedrock of new medical breakthroughs that improve patient outcomes worldwide. It ensures that your innovations are built on robust science, with clear data supporting safety, efficacy, and manufacturability.
Proactive R&D strategies help identify potential development hurdles early, reducing costly delays and increasing the likelihood of regulatory approval. It enables better decision-making and resource allocation, ultimately accelerating the path to market.
By partnering with Quraxia’s R&D team, you gain a trusted collaborator committed to scientific excellence, regulatory readiness, and delivering value at every stage—supporting your goals from discovery to life-changing medicines.
services offered
Antibody-Drug Conjugates
Targeted cancer therapies that combine precision antibodies with potent drugs, delivering treatment directly to cancer cells while minimizing damage to healthy tissue.
Aptamers (Oligonucleotides)
Custom synthesis of DNA/RNA aptamers that bind specifically to target molecules, offering versatile solutions for diagnostics, therapeutics, and research applications.
Peptide & Protein Synthesis
High-purity custom synthesis of therapeutic and research-grade peptides and proteins using advanced solid-phase synthesis, with characterization and quality assurance.
Biomarker
Advanced genomic and proteomic platforms to identify and validate biomarkers for early cancer detection, patient stratification, and precision therapy development.
Human Tissue Culture
Development of 3D tissue models including organoids and organ-on-a-chip systems for more accurate drug testing, disease modeling, and personalized medicine research.
API Development
End-to-end API development from route design to GMP manufacturing, specializing in complex molecules with full regulatory compliance and analytical support.
Monoclonal Antibody Development
Development of diagnostic and therapeutic monoclonal antibodies, paired with MALDI-MS profiling for advanced cancer detection and personalized treatment selection.
Extraction & Therapeutic Identification of Natural Products
Natural product extraction and development services for novel therapeutics, supporting discovery, and scalable formulation.
